STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
- Relapsed Sarcomas
- Disulfiram
- +2 more
- Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
2022-01-14
Jan 14, 2022M
Completed
- Breast Cancer
- Trastuzumab and non-pegylated liposomal doxorubicin
- Paris, France
- +3 more
2022-02-08
Feb 8, 2022S
Recruiting
- Angiosarcoma Metastatic
- Abraxane combined with liposomal doxorubicin
- Guangzhou, Guangdong, ChinaXing Zhang
2021-11-15
Nov 15, 2021Y
Terminated
- Relapsed Lymphomas
- Refractory Lymphomas
- Vorinostat
- Pegylated Liposomal Doxorubicin (PLD), Doxil
- New Haven, ConnecticutYale University School of Medicine
2022-03-29
Mar 29, 2022S
Recruiting
- Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
- Blood sampling
- Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
2021-12-21
Dec 21, 2021N
Recruiting
- Kaposi Sarcoma
- liposomal doxorubicin
- pomalidomide
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022H
A
Active, not recruiting
- Solid Tumors
- AZD2281
- liposomal doxorubicin
- Milano, Italy
- +2 more
2021-11-17
Nov 17, 2021M
Active, not recruiting
- Invasive Breast Carcinoma
- Triple-Negative Breast Carcinoma
- Bevacizumab
- +3 more
- Houston, TexasM D Anderson Cancer Center
2022-02-18
Feb 18, 2022R
Recruiting
- Lymphoma
- liposomal doxorubicin
- Shanghai, Shanghai, ChinaRuijin Hospital
2021-03-13
Mar 13, 2021G
Active, not recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
- Villejuif, Val De Marne, FranceGustave Roussy
2021-07-21
Jul 21, 2021S
Recruiting
- Breast Cancer
- pegylated liposomal doxorubicin (PLD)
- +5 more
- Guandong, Guangdong, ChinaSunyat-sen Memorial Hospital
2022-02-17
Feb 17, 2022Y
Recruiting
- Stage III Adult Soft Tissue Sarcoma
- Pegylated liposomal doxorubicin
- Anlotinib
- Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
2021-02-18
Feb 18, 2021A
Recruiting
- Pediatric Cancer
- +9 more
- Magnetic resonance high intensity focused ultrasound
- Lyso-thermosensitive liposomal doxorubicin
- Washington, District of ColumbiaChildren's National Medical Center
2021-12-10
Dec 10, 2021N
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Capecitabine
- +6 more
- Bethesda, MarylandNational Cancer Institute Developmental Therapeutics Clinic
2022-03-17
Mar 17, 2022E
T
Recruiting
- Ovarian Cancer
- +5 more
- TTI-622
- Pegylated Liposomal Doxorubicin
- Houston, TexasOncology Consultants, P.A.
2022-03-14
Mar 14, 2022R
Suspended
- Estrogen Receptor-negative Breast Cancer
- +8 more
- pegylated liposomal doxorubicin hydrochloride
- +6 more
- New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
2021-09-20
Sep 20, 2021N
Suspended
- Fallopian Tube Clear Cell Adenocarcinoma
- +25 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
- Aurora, Colorado
- +7 more
2022-04-05
Apr 5, 2022N
Completed
- Ovarian Neoplasms Malignant (Excl Germ Cell)
- +2 more
- trientine dihydrochloride
- +2 more
- (no location specified)
2020-10-18
Oct 18, 2020D
Active, not recruiting
- Ovarian Cancer
- +2 more
- Pembrolizumab
- Pegylated Liposomal Doxorubicin (PLD)
- Boston, Massachusetts
- +2 more
2021-09-03
Sep 3, 2021W
Not yet recruiting
- Breast Cancer
- Camrelizumab
- +2 more
- Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College of HUST
2021-10-27
Oct 27, 2021S
Terminated
- Ovarian Cancer
- +2 more
- Fort Myers, Florida
- +3 more
2021-10-04
Oct 4, 2021H
Terminated
- Ovarian Cancer
- Doxil (Pegylated Liposomal Doxorubicin)
- BIBF 1120
- Indianapolis, Indiana
- +1 more
2022-02-14
Feb 14, 2022M
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +4 more
- Phoenix, Arizona
- +2 more
2021-04-06
Apr 6, 2021